Clinical research organizations START and Advarra join forces, promising exceptional speed, quality, and reliability for initial oncology medical trials.
The START Center for Cancer Research, a global leader in community-based early-phase oncology research, has announced a strategic partnership with Advarra, a premier provider of clinical research solutions for sites and institutions. This alliance aims to create a seamless, end-to-end, patient-centric clinical trial workflow.
Key Components of the Partnership
The partnership will see START utilise Advarra’s portfolio of products and services, including its Independent Review Board (IRB) and Institutional Biosafety Committee (IBC) services, as the preferred provider. START sites will adopt Advarra’s OnCore Clinical Trial Management System (CTMS), which is already used by over 85% of NCI-designated cancer centers. The partnership will also deploy Advarra’s eReg system, an electronic regulatory management platform integrated with OnCore CTMS.
Impact on Oncology Drug Development
The alliance aims to accelerate trials, enhance quality and compliance, improve site connectivity, and focus on a patient-centric approach. By standardising processes and leveraging advanced technology, the partnership hopes to reduce trial timelines and alleviate pressures on the oncology drug development ecosystem.
The integration drives standardisation, data efficiency, and consistent high quality across START’s expanding network, which is critical for maintaining regulatory compliance and trial integrity. The creation of a seamlessly connected site network facilitates faster patient recruitment, data sharing, and operational coordination, which are often bottlenecks in early-phase oncology trials. The end-to-end workflow is designed to be patient-centric, potentially improving patient experience and retention in clinical trials.
Broader Implications
This strategic alliance positions START to further strengthen its leadership in oncology research by combining its extensive site network with Advarra’s regulatory and technological expertise. The result is expected to be faster, higher-quality, and more predictable early-phase oncology trials, ultimately benefiting patients, sponsors, and the broader cancer research community.
Contact Information
For more information about Advarra, visit advarra.com. The media contact for Advarra is Michelle Valentine ([email protected] or [email protected]). Additional PR contact for Advarra is Lisa Osborne ([email protected]).
Advarra's solutions aim to reimagine clinical research while improving compliance. They streamline trials by connecting patients, sites, sponsors, and CROs in a single ecosystem. The solutions prioritise collaboration, transparency, and efficiency to optimise trial operations. Advarra is a leader in clinical research solutions, providing services to top 50 global biopharma sponsors, top 20 CROs, and 50,000 site investigators worldwide. START's mission is to deliver "Hope Through Access," connecting patients, physicians, and advocacy groups with community-based cancer trials.
- The START Center for Cancer Research has partnered with Advarra, aiming to create a patient-centric clinical trial workflow by utilizing Advarra's Independent Review Board (IRB), Institutional Biosafety Committee (IBC) services, OnCore Clinical Trial Management System (CTMS), and eReg system.
- This alliance in cancer research aims to accelerate trials, enhance quality and compliance, and improve site connectivity, potentially reducing trial timelines and alleviating pressures on the oncology drug development ecosystem.
- The streamlined trial operations prioritized by Advarra's solutions are designed to drive standardization, data efficiency, and consistent high quality across START's expanding network, which is critical for maintaining regulatory compliance and trial integrity.
- The strategic partnership between START and Advarra is expected to benefit patients, sponsors, and the broader cancer research community by delivering faster, higher-quality, and more predictable early-phase oncology trials.
- For more information about Advarra's services in health-and-wellness, finance, business, technology, and science, visit their website at advarra.com. The media contact for Advarra is Michelle Valentine ([email protected] or [email protected]), and the additional PR contact is Lisa Osborne ([email protected]).
